; (C) the sharing of relevant health data, with respect to COVID–19, including testing and positivity rates, between health agencies within the United States-Mexico Border Area can be strengthened; and (D) a vaccine should be disbursed throughout the United States-Mexico Border Area, taking into account the various vulnerable populations in the region. (2) Implementation Not later than 60 days after the date of the enactment of this section, the Commission (acting with the participation of members representing both the United States and Mexican sections) shall develop, and publish on a public website of the Commission, what actions Federal agencies will take within the United States section and agencies of the Government of Mexico will take within the Mexican section of the United States-Mexico Border Area to facilitate implementation of the plan under paragraph (1). At least once each year after the publication of such information, the Commission shall submit to Congress a report on actions taken by Federal agencies and agencies of the Government of Mexico to facilitate that implementation during the year covered by the report. (c) Future infectious disease plan (1) In general Not later than 180 days after the date of the enactment of this section, the Commission shall develop and publish a plan to prepare and respond to infectious diseases (other than COVID–19) within the United States-Mexico Border Area. Such plan shall address how— (A) the United States-Mexico Border Area should strengthen its response to such infectious diseases, with a focus on testing, contact tracing, and other infection prevention and control measures; (B) the effect of such infectious diseases on the economic conditions in the United States-Mexico Border Area may be mitigated; (C) the sharing of relevant health data, with respect to such infectious diseases, including testing and positivity rates, between health agencies within the United States-Mexico Border Area can be strengthened